Literature DB >> 3400761

Analysis of tear proteins in Graves' ophthalmopathy by high performance liquid chromatography.

H A Khalil1, R J de Keizer, A Kijlstra.   

Abstract

Using high performance liquid chromatography, we analyzed tears from 50 patients with Graves' ophthalmopathy and 20 controls. With this technique, tear constituents are separated according to size; a normal tear protein profile consists of five peaks. An increase in one or more peaks was observed in 14 patients (28%) and in none of the controls. No decreased values were observed. No relation was observed between abnormalities of tear composition and the clinical NO SPECS classification. There was a tendency for increased tear protein peaks in those patients with long-standing disease. Most patients with an increase in one or more tear protein levels had normal thyroid function after treatment for hyperthyroidism. Our findings suggested that the inflammatory process in the orbit occurring in Graves' ophthalmopathy also had an effect on the lacrimal gland, which was reflected in the composition of the tears.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3400761     DOI: 10.1016/0002-9394(88)90832-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  Effect of contact lenses on the protein composition in tear film: a ProteinChip study.

Authors:  Christina Kramann; Nils Boehm; Katrin Lorenz; Nelli Wehrwein; Bernhard M Stoffelns; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-26       Impact factor: 3.117

2.  Secretory IgA and lysozyme in tears of patients with Graves' ophthalmopathy.

Authors:  H A Khalil; R J De Keizer; V M Bodelier; A Kijlstra
Journal:  Doc Ophthalmol       Date:  1989-08       Impact factor: 2.379

3.  The permeability of the corneal epithelium of Graves' ophthalmopathy as determined by fluorophotometry.

Authors:  H A Khalil; J A van Best; R J de Keizer
Journal:  Doc Ophthalmol       Date:  1989-11       Impact factor: 2.379

4.  Immunoglobulin A in Graves' orbital tissue: deoxyribonucleic acid amplification by polymerase chain reaction.

Authors:  S M McLachlan; M F Prummel; J C Jaume; B Rapoport
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

5.  Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.

Authors:  Danping Huang; Nuo Xu; Yiyue Song; Peijuan Wang; Huasheng Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-30       Impact factor: 3.117

Review 6.  The potential of tear proteomics for diagnosis and management of orbital inflammatory disorders including Graves' ophthalmopathy.

Authors:  Hadi Khazaei; Danesh Khazaei; Rohan Verma; John Ng; Phillip A Wilmarth; Larry L David; James T Rosenbaum
Journal:  Exp Eye Res       Date:  2021-11-03       Impact factor: 3.467

7.  The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

Authors:  Luigi Bartalena; Lelio Baldeschi; Kostas Boboridis; Anja Eckstein; George J Kahaly; Claudio Marcocci; Petros Perros; Mario Salvi; Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2016-03-02

8.  Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy.

Authors:  Jin Sook Yoon; Soo Hyun Choi; Joon H Lee; Sung Jun Lee; Sang Yeul Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-21       Impact factor: 3.117

9.  The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.

Authors:  Jelena Juri Mandić; Ana Kozmar; Sanja Kusačić-Kuna; Anamarija Jazbec; Krešimir Mandić; Danijela Mrazovac; Nenad Vukojević
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-14       Impact factor: 3.117

Review 10.  The relationship between Graves' ophthalmopathy and dry eye syndrome.

Authors:  Jessica H Selter; Anisa I Gire; Shameema Sikder
Journal:  Clin Ophthalmol       Date:  2014-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.